/ Print /

Christine Blank
Landmark study identifies asthma in infants
A Canadian study reveals how clinicians may be able to identify whether asthma will develop in patients as young as age one.
Two asthma treatment recommendations for health organizations
Allergist Bradley Chipps, MD, shares research on how to fine-tune asthma management strategies.
FDA clears first opioid withdrawal device
FDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.
How hospitals can cope with IV drug shortages
Because of the impact of Hurricanes Maria and Irma on Puerto Rico’s infrastructure and drug manufacturing, hospitals face an ongoing shortage of IV fluids manufactured there.
FDA approves first pill that can be tracked when ingested
FDA approved the first drug in the United States that has a digital ingestion tracking system, which records when the medication was taken.
FDA issues warning over marijuana products claiming cancer cure
FDA issues warning over marijuana products claiming cancer cure
FDA warned 4 companies, which are claiming that their products containing cannabidiol, can treat or cure cancer.
Game-changing hep B vaccine gets FDA nod
The first 2-dose hepatitis B vaccine, which was recently approved by FDA, is expected to be commercially available in early 2018.
FDA advisors recommend 2 opioid use disorder drugs
Two opioid use disorder drugs have been recommended for approval by FDA committees.
Activists: drugmakers, distributors liable for opioids abuse
Soon after President Donald Trump announced declared the opioid abuse crisis a “public health emergency," shareholder activist groups said they aim to hold drug manufacturers and distributors liable for their part in the crisis.
FDA okays unique injectable for type 2 diabetics
FDA approved a new once-weekly, single-dose autoinjector device to improve glycemic control in adults with type 2 diabetes.